ipilimumab,nivolumab
bms
['checkmate 743', 'nivo', 'check,mate,743', 'lcsm,(-blcsm)', 'ipilimumab', 'mesothelioma', 'nivolumab', ' ipi ']
4-year update from checkmate 743 nivolumab + ipilimumab vs chemotherapy in 1l unresectable malignant pleural #mesothelioma 4-year os: 17% vs 11% 4-year pfs: 9% vs 0% 16% of responders in the nivo + ipi have ongoing response at 4 years vs 0 in the chemo
#esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm